New drug cocktail aims to tame deadly transplant complication
Disease control
Recruiting now
This study tests whether adding the drug ruxolitinib to standard medications (cyclophosphamide and tacrolimus) can prevent severe graft-versus-host disease (GVHD) in people receiving stem cell transplants for blood cancers like leukemia. About 124 adults will receive the drug com…
Phase: PHASE2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC